Recurrent Atypical Hemolytic-Uremic Syndrome (aHUS) Associated With CD46 Genetic Mutation: A Report of a Rare Case.

Authors

• Navanita Biswas, Internal Medicine, Tower Health, Reading Hospital, West Reading, USAFollow
• Prakash Adhikari, Internal Medicine, Tower Health, Reading Hospital, West Reading, USAFollow
• Nisha Baral

Document Type

Article

Publication Date

2-12-2026

Abstract

Hemolytic-uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. The typical form of HUS is most often associated with Shiga toxin-producing

Publication Title

Cureus

Volume

18

Issue

2

First Page

103475

Last Page

103475

Recommended Citation

Biswas, N., Adhikari, P., & Baral, N. (2026). Recurrent Atypical Hemolytic-Uremic Syndrome (aHUS) Associated With CD46 Genetic Mutation: A Report of a Rare Case.. Cureus, 18 (2), 103475-103475. https://doi.org/https://doi.org/10.7759/cureus.103475